Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2012-2016

Puerto Rico 8 versus United States

All Races, Both Sexes

Cancer Site and Sex
 sort alphabetically by cancer site descending
Priority Index1
1=highest
9=lowest

 sort by priority index descending
Recent Trend2
County Death
Rate
Compared
to
US Rate
Average Annual Count
 sort by count descending
Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
 sort by rate descending
Rate
Ratio3
County
to
US
 sort by rate descending
Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
 sort by trend descending
Bladder (Female) 9 falling falling trend lower 36 1.3 (1.2, 1.6) 0.6 -5.0 (-9.6, -0.3)
Bladder (Male) 7 stable stable trend lower 82 4.2 (3.8, 4.7) 0.6 -3.6 (-12.2, 5.9)
Brain & ONS (Female) 7 stable stable trend lower 51 2.2 (1.9, 2.4) 0.6 4.0 (-19.4, 34.1)
Brain & ONS (Male) 7 stable stable trend lower 57 2.9 (2.6, 3.3) 0.5 -1.7 (-13.4, 11.6)
Breast (Female) 6 stable stable trend similar 434 17.8 (17.1, 18.6) 0.9 -0.1 (-3.6, 3.5)
Cervix (Female) 6 stable stable trend similar 51 2.4 (2.1, 2.7) 1.1 -1.5 (-12.6, 11.0)
Childhood (Ages <15, All Sites) (Female) 6 stable stable trend similar 5 1.8 (1.2, 2.7) 0.9 9.1 (-18.9, 46.9)
Childhood (Ages <15, All Sites) (Male) 7 stable stable trend lower 5 1.6 (1.1, 2.4) 0.7 -10.2 (-23.5, 5.6)
Childhood (Ages <20, All Sites) (Female) 6 stable stable trend similar 8 1.9 (1.4, 2.6) 0.9 -3.3 (-29.2, 32.0)
Childhood (Ages <20, All Sites) (Male) 6 stable stable trend similar 9 2.0 (1.5, 2.7) 0.8 -10.3 (-25.4, 8.0)
Colon & Rectum (Female) 6 stable stable trend similar 314 12.1 (11.5, 12.7) 1.0 -2.2 (-7.1, 3.0)
Colon & Rectum (Male) 4 stable stable trend higher 387 19.5 (18.6, 20.4) 1.2 -2.9 (-9.5, 4.1)
Esophagus (Female) 7 stable stable trend lower 21 0.8 (0.7, 1.0) 0.6 -8.8 (-17.7, 1.0)
Esophagus (Male) 7 stable stable trend lower 91 4.4 (4.0, 4.9) 0.6 -4.6 (-11.4, 2.7)
Kidney & Renal Pelvis (Female) 7 stable stable trend lower 30 1.2 (1.0, 1.4) 0.5 3.5 (-20.2, 34.3)
Kidney & Renal Pelvis (Male) 7 stable stable trend lower 54 2.7 (2.4, 3.0) 0.5 10.3 (-13.2, 40.1)
Leukemia (Female) 7 stable stable trend lower 80 3.3 (2.9, 3.6) 0.7 6.1 (-0.9, 13.5)
Leukemia (Male) 7 stable stable trend lower 100 5.3 (4.8, 5.8) 0.6 -0.3 (-3.7, 3.3)
Liver & Bile Duct (Female) 6 stable stable trend similar 113 4.3 (3.9, 4.7) 1.1 1.5 (-2.7, 5.9)
Liver & Bile Duct (Male) 6 stable stable trend similar 211 10.2 (9.6, 10.9) 1.1 0.0 (-7.9, 8.6)
Lung & Bronchus (Female) 9 falling falling trend lower 226 8.7 (8.2, 9.2) 0.3 -7.2 (-9.3, -5.0)
Lung & Bronchus (Male) 7 stable stable trend lower 376 18.7 (17.8, 19.6) 0.4 -5.9 (-12.8, 1.5)
Melanoma of the Skin (Female) 7 stable stable trend lower 7 0.3 (0.2, 0.4) 0.2 17.8 (-36.7, 119.3)
Melanoma of the Skin (Male) 7 stable stable trend lower 12 0.6 (0.4, 0.8) 0.2 3.3 (-35.1, 64.5)
Non-Hodgkin Lymphoma (Female) 7 stable stable trend lower 63 2.5 (2.2, 2.8) 0.6 -3.0 (-11.0, 5.7)
Non-Hodgkin Lymphoma (Male) 7 stable stable trend lower 90 4.7 (4.3, 5.1) 0.6 -1.7 (-9.0, 6.2)
Oral Cavity & Pharynx (Female) 7 stable stable trend lower 24 0.9 (0.8, 1.1) 0.7 -12.3 (-30.4, 10.5)
Oral Cavity & Pharynx (Male) 4 stable stable trend higher 101 5.0 (4.5, 5.4) 1.3 0.2 (-14.1, 17.0)
Ovary (Female) 9 falling falling trend lower 104 4.2 (3.8, 4.6) 0.6 -3.4 (-6.6, -0.1)
Pancreas (Female) 7 stable stable trend lower 143 5.5 (5.1, 5.9) 0.6 -5.9 (-15.3, 4.5)
Pancreas (Male) 7 stable stable trend lower 160 7.9 (7.3, 8.4) 0.6 -1.8 (-6.3, 3.0)
Prostate (Male) 5 falling falling trend higher 491 25.9 (24.9, 26.9) 1.3 -3.8 (-7.4, -0.1)
Stomach (Female) 4 stable stable trend higher 89 3.5 (3.1, 3.8) 1.5 -5.3 (-10.9, 0.5)
Stomach (Male) 4 stable stable trend higher 123 6.3 (5.8, 6.8) 1.5 -7.7 (-19.2, 5.4)
Thyroid (Female) 7 stable stable trend lower 9 0.3 (0.2, 0.5) 0.7 -1.1 (-18.4, 19.8)
Thyroid (Male) 6 stable stable trend similar 8 0.4 (0.3, 0.6) 0.8 14.2 (-4.5, 36.6)
Uterus (Corpus & Uterus, NOS) (Female) 6 stable stable trend similar 117 4.8 (4.4, 5.2) 1.0 5.8 (-6.3, 19.5)
Notes:
Created by statecancerprofiles.cancer.gov on 09/18/2019 12:59 am.

Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.7.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2016 US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).
8 Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected geographic areas.



Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top